Roth MKM analyst Richard Baldry upgraded CareCloud to Buy from Neutral with an unchanged $3 price target after the company announced that it intends to cut operating costs by $10M annually. The cost cutting plans leaves the firm viewing the company’s P&L and balance sheet as “now more defensible,” the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CCLD:
- CareCloud’s medSR implemented MEDITECH Expanse for Doctors Hospital Health
- CareCloud’s medSR Division Successfully Implements MEDITECH Expanse EHR at Doctors Hospital Bahamas, Enhancing Patient Care and Data Resilience
- CareCloud’s medSR division selected by Citizens Medical Center
- CareCloud’s medSR Division Selected by Citizens Medical Center for Vital MEDITECH Expanse Installation
- CareCloud’s RCM and EHR Solutions Named Best Medical Software for Large Practices by Business.com